Form 4 holding
10%+ Owner
Seres Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 5,825,495
- Estimated value
- $7,864,418
- Report date
- 05 Jul 2022
- Price
- $1.35
- Ownership
- By Flagship Pioneering Fund VII, L.P.